𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of locoregional therapy for hepatocellular carcinoma before liver transplantation: Answer or myth?

✍ Scribed by Teh-Ia Huo; Shou-Dong Lee; Jaw-Ching Wu


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
44 KB
Volume
12
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Reply: Role of locoregional therapy for
✍ Paige Porrett; Abraham Shaked; Kim Olthoff πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 34 KB πŸ‘ 1 views

Huo and colleagues 1 appropriately note that the low complete response rate to radiofrequency ablation (RFA) in our study contrasts markedly with much of the published literature. Their surprise regarding this finding originates from the commonly held belief that RFA effectively ablates hepatocellul

Treatment of hepatocellular carcinoma in
✍ Fred T. Lee Jr. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 65 KB πŸ‘ 1 views

Hepatocellular carcinoma (HCC) in the setting of cirrhosis continues to increase in both the United States and abroad because of the widespread incidence of hepatitis B and C. Before the advent of transplantation, liver resection was the only method to achieve cure. However, resection is associated

Neoadjuvant therapies for hepatocellular
✍ Patricia M. Lopez; Augusto Villanueva; Sasan Roayaie; Josep M. Llovet πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 133 KB

Hepatocellular carcinoma (HCC) is a major health problem, being the fifth most common cancer worldwide. 1 The incidence of HCC is increasing in Europe and the United States, 2 and it is currently the leading cause of death among patients with cirrhosis. 3 The advent of surveillance programs has led